How long does low dose naltrexone stay in your system

LDN has a 4-6 hour half-life and clears your system in 20-30 hours. Here's exactly how long it lasts, what affects elimination speed, and why timing matters.

import { QuickAnswerBox, FAQSection, RelatedGuides, ArticleCTA, TipBox, WarningBox, TableOfContents, Timeline, DataTable, ArticleBreadcrumb } from '@/components/articles'

You take your LDN dose at bedtime. By morning, is it gone? And why does that even matter?

These are surprisingly important questions. Not just for people worried about drug tests, but for anyone managing their LDN timing around opioid medications, upcoming surgeries, or other compounds. Get the timing wrong and LDN either doesn't work the way it should, or it actively blocks pain relief when you need it most.

Here's what most resources get wrong: they treat LDN exactly like standard-dose naltrexone. It's not the same drug in practice. The dose difference changes the entire pharmacological picture. At 1.5 to 4.5 mg, naltrexone works through a completely different mechanism than it does at 50 mg. The timing matters. The clearance matters. Understanding both helps you use LDN intelligently.

WinAging covers the science behind compounds like LDN, so you can make smarter decisions without spending hours in academic papers. This guide breaks down everything you need to know about how long LDN stays in your system and what that means practically.

What is low dose naltrexone {#what-is-ldn}

Naltrexone is an FDA-approved opioid antagonist, used since the 1980s at 50 mg doses to treat opioid and alcohol dependence. It blocks opioid receptors completely and keeps them blocked for 24 to 72 hours at that dose. That's the standard version. LDN is a different animal.

Low dose naltrexone sits between 1.5 and 4.5 mg. Sometimes lower. At this dose, naltrexone doesn't block opioid receptors for the whole day. It blocks them briefly. It clears quickly. And that's intentional. The short receptor blockade triggers a rebound effect that's the whole basis for LDN's therapeutic value.

LDN isn't FDA-approved for the off-label uses it's most popular for. It has to be compounded at a specialty pharmacy. Doctors prescribe it for autoimmune conditions, chronic pain, fibromyalgia, Crohn's disease, multiple sclerosis, and a growing list of other conditions where inflammation and immune dysregulation are part of the picture.

Scientific research lab with warm golden light, representing LDN pharmacokinetics research

The community of people using LDN is large and vocal. Many report significant improvements after years of struggling with conditions that didn't respond to standard treatments. The research is still catching up, but clinical trials have produced encouraging results for several conditions. And the side effect profile at low doses is remarkably clean compared to most drugs.

But understanding how LDN behaves in your body matters before you start. The timing, the dosing window, what you can't take with it, and how to handle surgery aren't just pharmacology trivia. They're practical knowledge that affects whether LDN actually works for you.

Half-life and elimination time {#half-life-elimination}

Let's start with the core numbers, then explain what they mean.

The half-life of naltrexone at low doses is approximately 4 to 6 hours. Some research cites a range of 3.9 to 10.3 hours depending on the individual. After oral administration, the drug peaks in your bloodstream within one hour, then begins clearing rapidly.

There's also a primary metabolite to think about: 6-beta-naltrexol (often written as 6-β-naltrexol). When your liver processes naltrexone, it converts a significant portion to this metabolite, which also has opioid antagonist activity. 6-β-naltrexol has a longer half-life of about 13 hours. So even after the parent drug is gone, this metabolite keeps some level of receptor interaction going.

Here's how the elimination timeline breaks down:

The key practical takeaway: LDN at a standard 4.5 mg bedtime dose is substantially cleared by the time you wake up. That 10-12 hour window is by design. It's not a flaw in the drug. It's how LDN produces its therapeutic effect, which we'll cover in the next section.

Why taking LDN at night makes pharmacological sense

Most prescribers recommend taking LDN between 9 PM and 3 AM. The rationale is timing the brief receptor blockade to coincide with the body's natural endorphin production, which peaks during sleep. Block receptors during peak endorphin production, trigger the rebound, and the effect persists through the day when you need it.

If you take LDN in the morning, you're not maximizing the mechanism. You're also more likely to be taking other compounds that could interact. The bedtime protocol isn't arbitrary. It's based on when the drug does its best work given its short half-life.

Why the short half-life is the whole point {#why-short-half-life-matters}

This is the part that confuses people who compare LDN to standard naltrexone.

At 50 mg, naltrexone stays in your system for 24-72 hours and provides continuous opioid blockade. That's what you want for addiction treatment. You need sustained receptor blockade to prevent opioid effects. But for LDN's off-label uses, continuous blockade would actually defeat the purpose.

Here's the mechanism: your body treats brief opioid receptor blockade as a temporary deprivation signal. It responds by upregulating endorphin production and increasing receptor sensitivity. Then, when LDN clears in 10-12 hours, the newly elevated endorphins hit more sensitive, more plentiful receptors. This rebound effect is thought to be part of why LDN reduces pain, improves mood, and supports immune regulation.

There's a second mechanism running simultaneously. Naltrexone at low doses also acts as an antagonist at Toll-like Receptor 4 (TLR4), a receptor found on microglia, the brain's immune cells. TLR4 is a major driver of neuroinflammation. By blocking it, LDN is thought to reduce chronic inflammatory signaling in the brain and body. This TLR4 mechanism appears to be unique to low doses and completely independent from the opioid receptor story.

Person taking supplement in the morning, representing LDN timing protocol

So the short half-life serves the mechanism. The drug needs to clear so the rebound can happen. At 50 mg, full blockade eliminates the rebound entirely. That's why you can't just take a small piece of a standard naltrexone tablet and call it LDN. The compounded formulation is designed specifically to clear at the right rate.

This also explains why people who accidentally take higher doses of LDN (or compound it incorrectly) don't get the same results. Too much naltrexone for too long = no rebound. No rebound = no therapeutic benefit from the endorphin pathway.

Understanding this mechanism also shapes how you think about interactions with other compounds. Anything that affects opioid receptors interferes with the mechanism. Check our supplement interaction checker before adding anything to your LDN protocol. Some compounds people wouldn't expect interfere with opioid signaling at higher doses.

Detection windows by test type {#detection-windows}

If you're asking about drug tests, here's the complete picture for naltrexone by test type.

One nuance worth knowing: naltrexone is not on standard drug testing panels. Most workplace or probation drug tests look for narcotics, amphetamines, benzodiazepines, cannabinoids, and cocaine. They're not designed to detect naltrexone. So in most real-world situations, LDN won't show up on a drug test at all.

The exception is a false positive risk. Naltrexone's metabolite noroxymorphone can occasionally trigger a false positive result for oxycodone on urine immunoassay tests. This is rare but documented. If you're subject to drug testing and taking LDN, inform the testing administrator. Confirmatory testing (GC-MS) would identify the actual compound and clear up any confusion immediately.

For people on supervised medication programs where naltrexone compliance needs to be confirmed, testing windows matter in the other direction. Blood and urine tests can confirm recent dosing within the first day. Hair follicle tests can show compliance over the past 90 days.

What affects how long it stays in your system {#factors-affecting-duration}

The 4-6 hour half-life is an average. Several factors shift it meaningfully in either direction.

Liver function

Naltrexone is primarily metabolized by the liver through reduction to 6-β-naltrexol. If your liver function is impaired, whether from disease, chronic alcohol use, or certain medications, naltrexone clearance slows down. The drug stays active longer than expected. This matters for dosing and for timing interactions with opioids.

People with significant hepatic impairment typically need dose adjustments and closer monitoring. Standard LDN doses that clear in 10-12 hours for healthy individuals may persist much longer in someone with compromised liver function.

Kidney function

The kidneys handle elimination of naltrexone and its metabolites. Renal impairment slows elimination. If you have kidney disease or reduced renal function, naltrexone accumulates more than it should relative to dose. The effective half-life extends.

Age and body composition

Older adults often have reduced liver and kidney function as a normal part of aging. Drug metabolism generally slows with age. A 70-year-old and a 35-year-old taking the same 4.5 mg dose may have meaningfully different clearance timelines. This is one reason dosing often starts lower in older patients and titrates up slowly.

Body composition affects drug distribution. Highly lipophilic drugs accumulate in fat tissue. Naltrexone is relatively hydrophilic, so body fat isn't a major factor compared to drugs like cannabinoids. Muscle mass and lean body mass do influence renal clearance rates to some extent.

Genetics

Cytochrome P450 enzymes govern a huge amount of drug metabolism. Genetic variants in these enzymes can make someone a fast metabolizer (drug clears faster than average) or a slow metabolizer (drug lingers longer). Without pharmacogenomic testing, you can't know your status in advance. But if LDN seems either very potent or strangely ineffective at a standard dose, variable metabolism is worth discussing with your prescriber.

Other medications

Several drugs inhibit the liver enzymes that clear naltrexone. If you're taking strong CYP3A4 inhibitors like certain antifungals, some antibiotics, or HIV medications, naltrexone may stay in your system longer than expected. The reverse applies for CYP3A4 inducers, which can speed up clearance.

The WinAging supplement interaction checker is a good first pass for supplement-level interactions. For pharmaceutical interactions, your prescriber or pharmacist is the definitive resource.

Doctor reviewing patient chart during consultation about LDN therapy

When to stop LDN before surgery {#before-surgery}

This is one of the most practically important questions about LDN timing, and it's one where you really can't afford to get it wrong.

The problem is straightforward. Surgery almost always involves opioid-based anesthesia and post-operative pain management. If naltrexone is still blocking opioid receptors when your anesthesiologist gives you fentanyl or morphine, two bad things happen. First, the opioid may be ineffective or require dramatically higher doses to achieve analgesia. Second, the interaction is unpredictable and potentially dangerous.

Different experts recommend different stop times, and there's no single consensus. Here's the range:

48 hours prior: The most commonly cited minimum. Given the 4-6 hour half-life, stopping 48 hours before should provide full clearance of the parent drug. This is the recommendation from many LDN prescribers for elective procedures.

72 hours prior: A more conservative window that accounts for individual variability in metabolism, the 6-β-naltrexol metabolite's longer half-life, and some buffer for people with slower clearance. Probably the safest minimum for most patients.

7 days prior: Some sources, particularly for major surgeries, recommend stopping a full week beforehand. This accounts for the full range of metabolic variation and provides maximum safety margin. If you have liver or kidney issues, this extended window is worth discussing with your surgeon.

The emergency situation: If you need emergency surgery and can't stop LDN in advance, tell your surgical team immediately. Let them know your dose and when you last took it. They can adjust anesthetic protocols accordingly. LDN doesn't make anesthesia impossible. It makes careful communication with your providers non-negotiable.

Never assume your surgeon or anesthesiologist knows you're taking LDN. Always disclose it, along with your dose and when you last took it. LDN is compounded and doesn't appear in standard electronic health records the way a pharmacy-dispensed medication would.

Restarting after surgery

Once you're no longer using opioid pain medications post-surgery, you can typically restart LDN. Most prescribers recommend waiting until you're completely off opioids, then waiting an additional 24-48 hours before resuming.

If you've been off LDN for more than two weeks, re-titrate from a lower dose rather than jumping back to your previous dose. The receptors will have regained baseline sensitivity and you don't want to overshoot. Your prescriber should guide this. Understanding what to avoid when taking low dose naltrexone covers this territory in more detail, including the full list of substances that interact with LDN.

LDN and opioid timing {#opioid-interactions}

The core conflict between LDN and opioids isn't complicated. Naltrexone blocks the same receptors that opioids activate. Take them together and you're fighting over the same parking spaces.

If you take an opioid medication while LDN is still active in your system, two outcomes are possible:

The opioid doesn't work. Naltrexone has higher receptor affinity than most opioids. It's sitting on the receptor. The opioid has nowhere to bind. You take a painkiller and feel nothing, or feel far less than expected. For moderate pain after minor dental work, that might be tolerable. For post-surgical pain, it could be a genuine crisis.

Precipitation of withdrawal symptoms. If you have opioid dependency (even tolerance from prescribed medications) and naltrexone displaces opioids from receptors rapidly, you can trigger acute withdrawal. This happens with standard naltrexone too, and it's one reason providers are careful about timing when initiating naltrexone therapy.

The reverse problem also applies. If you take an opioid and it's still active in your system when you take LDN, the LDN blocks the opioid without displacing the mechanism smoothly. You don't get the LDN rebound effect, and the opioid's remaining action gets cut off.

The practical rules:

For scheduled opioid pain medications, LDN is generally contraindicated unless your prescriber has designed a very specific protocol. These two drugs don't coexist well on a routine basis.

For over-the-counter pain medications like NSAIDs (ibuprofen, naproxen) or acetaminophen (Tylenol), there's no interaction. These don't work through opioid receptors. You can take them with LDN without concern.

For tramadol, it's more complicated. Tramadol has a dual mechanism including opioid receptor activity. Use it with LDN requires careful thought and prescriber guidance.

For kratom and other opioid-containing botanicals, the same principles apply as with pharmaceutical opioids. Don't combine with LDN unless you've discussed it thoroughly with whoever prescribes your LDN.

If you're building a comprehensive protocol and want to see how various compounds interact, our supplement interaction checker handles many common combinations. For pharmaceutical drug interactions specifically, pharmacist review is the gold standard.

Conditions LDN is used for {#conditions-ldn-helps}

LDN has developed a following in the chronic disease and longevity communities partly because it addresses inflammation and immune dysregulation at a fundamental level. Both the endorphin rebound mechanism and the TLR4 anti-inflammatory pathway are relevant to a wide range of conditions that have those two features in common.

Here's what the clinical research shows, condition by condition.

Fibromyalgia

Fibromyalgia has the strongest evidence base for LDN among off-label uses. Multiple clinical trials have shown that low dose naltrexone reduces pain, improves sleep quality, reduces fatigue, and helps with cognitive symptoms ("fibro fog"). A 2023 systematic review concluded the evidence supports LDN as a safe and potentially effective option.

The mechanism here is both the endorphin rebound and the TLR4 pathway. Central sensitization, the process that amplifies pain signals in fibromyalgia, involves both opioid receptor dysregulation and glial inflammation. LDN addresses both.

Person experiencing relief from chronic pain, representing LDN's therapeutic benefits

Crohn's disease

A landmark pilot study of LDN in Crohn's disease found that 88% of patients showed clinical response and 33% achieved remission. Follow-up studies have been similarly encouraging. LDN appears to reduce gut inflammation through its effect on TLR4 and by increasing endogenous enkephalins, which are opioids produced by intestinal tissue that regulate gut motility and inflammation.

For people with Crohn's who've cycled through biologics and immunosuppressants, LDN represents a different mechanism entirely. That's part of its appeal: it works on pathways that the standard drugs don't target.

Multiple sclerosis

Research on LDN in MS has shown improvements in quality of life and mental health, with some studies showing benefits for fatigue and disability scores. The anti-neuroinflammatory mechanism is particularly relevant here, since MS involves inflammatory damage to myelin in the central nervous system.

LDN doesn't stop MS progression the way disease-modifying therapies do. But it may improve day-to-day functioning and reduce symptom burden for some patients, with a much more favorable side effect profile than immunosuppressive drugs.

Autoimmune conditions generally

The pattern across autoimmune conditions is consistent: where inflammation and immune dysregulation are central to the disease process, LDN often shows benefit. Conditions including psoriasis, lupus, Hashimoto's thyroiditis, rheumatoid arthritis, and CRPS have all been studied or reported in case series.

The evidence quality varies significantly. For some conditions, you're looking at solid randomized controlled trial data. For others, you're working from case reports and community experience. Part of the challenge with LDN is that it's cheap, unpatentable, and compounded, so there's limited commercial incentive to fund large trials.

Chronic pain

Beyond specific diagnoses, LDN has been used for chronic pain conditions where central sensitization plays a role. This includes complex regional pain syndrome, chronic low back pain, and post-surgical pain syndromes. The endorphin rebound provides a plausible mechanism for pain reduction that's distinct from how analgesics and opioids work.

If you're working with a functional medicine or longevity-oriented physician to optimize your overall health, LDN might come up as part of a broader anti-inflammatory protocol. The WinAging protocol builder takes your health profile and goals into account when building personalized longevity stacks. For LDN specifically, you'll always need a prescribing physician, but understanding where it fits in the bigger picture helps you have more productive conversations with your care team.

What LDN doesn't help with

It's worth being clear-eyed about limitations. LDN is not a primary treatment for most conditions it's used for. It's often adjunctive: used alongside other therapies to reduce symptom burden. The clinical trial base, while promising, is mostly small studies. Many are open-label without placebo control.

Autoimmune symptoms are highly variable. What works well for one person with Crohn's may do nothing for another with seemingly identical disease. LDN is not a cure. It's a tool that helps some people significantly, helps others modestly, and doesn't help a portion of users at all.

Symptoms of too much LDN covers what happens when doses get too high or titration is too aggressive. Start low, go slow is the standard guidance for good reason.

LDN requires a prescription and compounding pharmacy. Telehealth has made access easier than it was five years ago. See our guide on **[how to get low dose naltrexone](/blog/how-to-get-low-dose-naltrexone)** for a practical walkthrough of the process, including what to tell your doctor and which pharmacies compound it.

How LDN compares to standard naltrexone by duration

It's worth pausing on this comparison since people often confuse the two.

Standard naltrexone at 50 mg has the same intrinsic half-life as LDN, roughly 4-6 hours for the parent drug. But at 50 mg, the dose is so much larger that meaningful receptor blockade persists for 24-72 hours even as the drug clears. You're flooding the system. Even at low residual plasma concentrations, enough drug remains to block receptors effectively.

LDN at 1.5-4.5 mg clears below the receptor-blocking threshold much faster. The 10-12 hour window when LDN is "mostly gone" is a practical reality because the dose is too low to maintain meaningful blockade much beyond that timeframe. The brief window is what makes the rebound mechanism possible.

This also means you can't substitute standard naltrexone for LDN at a proportionally smaller dose. The formulation matters. Compounded LDN is often made with specific diluents and release profiles designed for the low-dose application. How to get low dose naltrexone covers the compounding options and what to ask a specialty pharmacy.

Monitoring your response over time {#monitoring}

Once you start LDN, what should you actually track?

Most people don't notice dramatic effects in the first week. LDN typically takes 4-12 weeks to show meaningful results, with some conditions responding faster than others. The gradual onset reflects the time needed for endorphin receptor upregulation and immune modulation to produce downstream effects.

What to watch in the early weeks:

Sleep. Vivid dreams are a commonly reported side effect during the first 1-2 weeks, particularly in the first days after starting. They usually resolve. If sleep is severely disrupted, shifting the dose to earlier in the evening sometimes helps.

Energy and mood. Many people notice improved energy and mood in the 4-8 week window. This is often attributed to the endorphin rebound mechanism becoming established.

Pain scores. Keep a simple daily pain log if you're taking LDN for pain management. You need baseline data to evaluate whether it's working. Subjective pain is notoriously subject to placebo and regression to the mean. Systematic tracking helps you tell the difference.

Inflammatory markers. If you have access to regular labs (CRP, ESR, relevant disease-specific markers), tracking these over 3-6 months gives you objective data on whether LDN is moving the needle on inflammation.

The biological age calculator doesn't directly measure LDN response, but tracking overall wellness metrics over time gives you context for whether interventions are working holistically. And WinAging's tools let you check for interactions with other supplements you're stacking alongside LDN.

LDN's short half-life isn't a limitation. It's the mechanism. Understanding that one fact explains the bedtime dosing, the opioid interaction rules, the surgery timing, and why the compounded formulation matters.

If you're exploring LDN as part of a broader longevity or anti-inflammatory protocol, start by reading what to avoid when taking low dose naltrexone and how to get low dose naltrexone. Both will save you time and frustration as you navigate the compounding and prescribing process.

Want to see how LDN fits into a personalized longevity protocol alongside other compounds? The WinAging AI protocol builder builds customized stacks based on your goals, health history, and current supplements, so you can see the full picture rather than optimizing individual compounds in isolation.